Clinical trial
A Controlled Study of Olanzapine in Children With Autism
NCT00057408 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Controlled Study of Olanzapine in Children With Autism
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- September 30, 2005
- Enrollment
- 78 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.